Thus, it is possible that dysregulated bile acid signaling in NAFLD and NASH patients cannot activate TGR5 in L cells, leading to aggravate disrupted cAMP and BMP signaling for GLP-1 secretion in response to nutrients such as glucose. The gene discussed is GPBAR1; the disease is metabolic dysfunction-associated steatotic liver disease.